$NOC

Northrop Grumman (NOC) Is Down This Year and Trades Below Its History and Peers. Time to Buy the Dip?

Northrop Grumman (NOC) shares are down 11% YTD, trading below historical and sector valuations. The company reported Q2 sales of $10.88B, up 10% sequentially, and raised full-year guidance. Operating margins declined, but backlog grew to $105B. Analysts debate whether the stock's discount is justified or presents a buying opportunity.

Original reporting
Published Oct 17, 2026, 5:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 17, 2026, 5:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Northrop Grumman (NOC) Is Down This Year and Trades Below Its History and Peers. Time to Buy the Dip? — source image
Decision brief

The 30-second read

$NOCNeutralMed
01

Why it matters

It frames the stock as a potential value opportunity tied to a margin recovery in 2H 2026, while emphasizing near-term risks from margin pressure, contract losses, and program charges.

02

Market read

Traders get a guidance update plus the margin and charge context, but the article is still largely a valuation and thesis discussion ahead of the next earnings print.

03

What to watch

The article cites a tax-rate explanation for the EPS beat and highlights capex ramp for B-21 production, both of which can complicate how quickly free cash flow and margins normalize.

Relevance 5/10Novelty 5/10Timing: into the Oct 20, 2026 Q3 results window

Background

The piece argues the defense demand cycle is strong, yet Northrop Grumman’s shares are down over 11% YTD, trading below its own and the sector’s valuation history.

Company-level read

Ticker impact

$NOCNeutralMedium confidence
Context

Northrop Grumman reported Q2 results and lifted full-year sales and adjusted EPS guidance, while margin fell to 10.1% and backlog hit a record $105B.

Expected impact

Likely mixed-to-negative near term as investors weigh margin weakness and charges against the guidance increase and backlog strength.

Evidence & confidence

The article’s decision-relevant items are the guidance raise (positive) and the margin decline plus specific program charge (negative), with the thesis hinging on whether margins recover in 2H 2026.

Market effects

Defense primes may trade on margin durability and fixed-price program risk even amid strong demand cycles.

Primarily US defense equities sentiment, with potential read-through to US defense procurement expectations.

Global NATO spending tailwinds support the group, but execution risk can still drive valuation dispersion.

Counterpoint

The valuation discount may reflect structural margin headwinds from fixed-price exposure and recurring program charges, not a temporary dip.

Key entities

  • Northrop Grumman Corporation

    Defense prime reporting Q2 results, lifting full-year guidance, and facing margin pressure and program charges.

  • GEM 63XL program

    Cited as having an unfavorable $91 million charge in the quarter, contributing to margin weakness.

  • B-21 Raider

    Production ramp cited as driving future capex and potential free-cash-flow impacts.

Related articles

$RTXMed

Defense Watch: RTX C-UAS Award, MQ-25 Software Test, PrSM Inc. 4, Taiwan V-BAT, Autonomous Black Hawk

RTX's Raytheon received a $729M contract for C-UAS systems. Boeing tested MQ-25 software, enabling autonomous coordination. The Navy awarded MQ-25A production contracts and tested automatic landing gear retraction. AeroVironment's VideoRay demonstrated autonomous mine countermeasures. Lockheed Martin delivered a C-130J for TACAMO conversion, with Northrop Grumman integrating systems. ThinKom provided SATCOM antennas for the E-130J Phoenix II. XTEND, Orqa, and Swarm received DoD drone awards.

$LMTLow

U.S. Navy Receives C-130J-30 for Planned E-130J TACAMO Mission

The U.S. Navy received a C-130J-30 from Lockheed Martin for the E-130J TACAMO mission, which will replace the E-6B Mercury. The aircraft will be modified by Northrop Grumman under a $3.46B contract. The GAO noted potential development risks, including operational-availability concerns and manufacturing difficulties. The critical design review is scheduled for late 2027, with no operational service date provided.

$LMTMed

Redburn Starts Coverage of U.S. Defense Stocks With Buy Ratings on Lockheed, Northrop and Kratos

Redburn initiated coverage of U.S. defense stocks, rating Lockheed Martin (LMT), Northrop Grumman (NOC), and Kratos (KTOS) as 'buy' with price targets of $650, $680, and $70, respectively. AeroVironment (AVAV) was rated 'neutral'. The brokerage cited a proposed $1.5 trillion U.S. military budget for fiscal 2027 as a potential demand driver. Redburn forecasts significant revenue and earnings growth for these companies through 2030.